102 related articles for article (PubMed ID: 20826570)
61. A novel vitamin K1 2,3-epoxide reductase (VKOR) inhibitor, 3-acetyl-5-methyltetronic acid, reduces experimental glomerulonephritis.
Uchida M; Sakaguchi Y; Miyamoto Y
J Vet Med Sci; 2012 Jul; 74(7):863-9. PubMed ID: 22322189
[TBL] [Abstract][Full Text] [Related]
62. Effect of Everolimus versus Bone Marrow-Derived Stem Cells on Glomerular Injury in a Rat Model of Glomerulonephritis: A Preventive, Predictive and Personalized Implication.
Zedan MM; Mansour AK; Bakr AA; Sobh MA; Khodadadi H; Salles EL; Alhashim A; Baban B; Golubnitschaja O; Elmarakby AA
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008770
[TBL] [Abstract][Full Text] [Related]
63. The effect of renal administration of a selective cyclooxygenase-2 inhibitor or stable prostaglandin I2 analog on the progression of sclerotic glomerulonephritis in rats.
Nozawa Y; Sato A; Piao H; Morioka T; Narita I; Oite T
Clin Exp Nephrol; 2012 Apr; 16(2):221-30. PubMed ID: 22147282
[TBL] [Abstract][Full Text] [Related]
64. Serial alterations of glomerular matrix-degrading metalloproteinase activity in anti-thymocyte-induced glomerulonephritis in rats.
Sato Y; Fujimoto S; Hamai K; Eto T
Nephron; 1998; 78(2):195-200. PubMed ID: 9496737
[TBL] [Abstract][Full Text] [Related]
65. Thy-1 antigen mediates apoptosis of rat glomerular cells in vitro and in vivo.
Morita H; Isobe K; Cai Z; Miyazaki T; Matsumoto Y; Shinzato T; Yoshikai Y; Kimata K; Maeda K
Nephron; 1996; 73(2):293-8. PubMed ID: 8773358
[TBL] [Abstract][Full Text] [Related]
66. PDGF-D inhibition by CR002 ameliorates tubulointerstitial fibrosis following experimental glomerulonephritis.
Boor P; Konieczny A; Villa L; Kunter U; van Roeyen CR; LaRochelle WJ; Smithson G; Arrol S; Ostendorf T; Floege J
Nephrol Dial Transplant; 2007 May; 22(5):1323-31. PubMed ID: 17308324
[TBL] [Abstract][Full Text] [Related]
67. Supplementation of heterologous complement induces anti-Thy-1.1 nephritis in the Mongolian gerbil (Meriones unguiculatus).
Shichinohe K; Shimizu-Suganuma M; Ghazizadeh M; Ishizaki M
J Vet Med Sci; 2002 Jun; 64(6):463-7. PubMed ID: 12130828
[TBL] [Abstract][Full Text] [Related]
68. Models of renal insufficiency: the anti-thy-1.1 model of acute proliferative glomerulonephritis.
Reinhart GA; Cox BF
Curr Protoc Pharmacol; 2001 May; Chapter 5():Unit5.21. PubMed ID: 21965074
[TBL] [Abstract][Full Text] [Related]
69. Immunohistochemical quantitation for extracellular matrix proteins in rats with glomerulonephritis induced by monoclonal anti-Thy-1.1 antibody.
Manabe N; Furuya Y; Nagano N; Yagi M; Kuramitsu K; Miyamoto H
Nephron; 1995; 71(1):79-86. PubMed ID: 8538853
[TBL] [Abstract][Full Text] [Related]
70. Induction of irreversible glomerulosclerosis in the rat by repeated injections of a monoclonal anti-Thy-1.1 antibody.
Morita H; Maeda K; Obayashi M; Shinzato T; Nakayama A; Fujita Y; Takai I; Kobayakawa H; Inoue I; Sugiyama S
Nephron; 1992; 60(1):92-9. PubMed ID: 1738421
[TBL] [Abstract][Full Text] [Related]
71. Effects of chitosan-coated dialdehyde cellulose, a newly developed oral adsorbent, on glomerulonephritis induced by anti-Thy-1 antibody in rats.
Yagi M; Kato S; Nishitoba T; Sato H; Kobayashi N; Iinuma N; Nagano N
Nephron; 1998; 78(4):433-9. PubMed ID: 9578070
[TBL] [Abstract][Full Text] [Related]
72. Lycium barbarum polysaccharides attenuate rat anti-Thy-1 glomerulonephritis through mediating pyruvate dehydrogenase.
Lu T; Zhao WE; Zhang F; Qi X; Yang Y; Gu C
Biomed Pharmacother; 2019 Aug; 116():109020. PubMed ID: 31152928
[TBL] [Abstract][Full Text] [Related]
73. Pharmacokinetics, disease-modifying activity, and safety of an experimental therapeutic targeting an immunological isoform of macrophage migration inhibitory factor, in rat glomerulonephritis.
Höllriegl W; Bauer A; Baumgartner B; Dietrich B; Douillard P; Kerschbaumer RJ; Höbarth G; McKee JS; Schinagl A; Tam FWK; Thiele M; Weber A; Wolfsegger M; Turecek M; Muchitsch EM; Scheiflinger F; Glantschnig H
Eur J Pharmacol; 2018 Feb; 820():206-216. PubMed ID: 29274331
[TBL] [Abstract][Full Text] [Related]
74. The influence of EPO and hypothermia on the kidneys of rats after perinatal asphyxia.
Stojanović V; Vučković N; Spasojević S; Barišić N; Doronjski A; Zikić D
Pediatr Nephrol; 2012 Jan; 27(1):139-44. PubMed ID: 21720803
[TBL] [Abstract][Full Text] [Related]
75. Mesangial cell necrosis in Thy 1 glomerulonephritis--an ultrastructural study.
Mosley K; Collar J; Cattell V
Virchows Arch; 2000 Jun; 436(6):567-73. PubMed ID: 10917170
[TBL] [Abstract][Full Text] [Related]
76. Effects of various antiplatelet drugs and defibrinating agent on experimental glomerulonephritis in rats.
Ogawa S; Naruse T
J Lab Clin Med; 1982 Mar; 99(3):428-41. PubMed ID: 6460069
[TBL] [Abstract][Full Text] [Related]
77. Early biomarkers of renal injury and protective effect of erythropoietin on kidneys of asphyxiated newborn rats.
Stojanović VD; Vučković NM; Barišić NA; Srdić B; Doronjski AD; Peco Antić AE
Pediatr Res; 2014 Jul; 76(1):11-6. PubMed ID: 24713815
[TBL] [Abstract][Full Text] [Related]
78. Nephritogenic glycoprotein. XII. Focal glomerulonephritis with myeloid bodies produced in rats by synthetic analogues of the glycopeptide, nephritogenoside.
Shibata S; Okada M; Natori Y; Shindo N; Oshima M
Nephron; 1987; 47(2):101-8. PubMed ID: 2827042
[TBL] [Abstract][Full Text] [Related]
79. Topiramate and darbepoetin alpha ameliorate bilirubin-induced neuronal cell damage.
Baysal B; Tüzün F; Yücesoy E; Özbal S; Uğur BE; Sonmez A; Olgun Y; Kirkim G; Evin H; Duman N; Kumral A; Yılmaz O; Ozkan H
Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3585-3593. PubMed ID: 34002833
[TBL] [Abstract][Full Text] [Related]
80. DMOG, a Prolyl Hydroxylase Inhibitor, Increases Hemoglobin Levels without Exacerbating Hypertension and Renal Injury in Salt-Sensitive Hypertensive Rats.
Kato S; Takahashi T; Miyata N; Roman RJ
J Pharmacol Exp Ther; 2020 Feb; 372(2):166-174. PubMed ID: 31801803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
